サルコイドーシス(Sarcoidosis):治療薬開発パイプライン動向2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVP501631)
◆英語タイトル:Sarcoidosis-Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVP501631
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[サルコイドーシス(Sarcoidosis):治療薬開発パイプライン動向2015]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるサルコイドーシス(Sarcoidosis)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、サルコイドーシス(Sarcoidosis)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・サルコイドーシス(Sarcoidosis)の概要

・サルコイドーシス(Sarcoidosis)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・サルコイドーシス(Sarcoidosis)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・サルコイドーシス(Sarcoidosis)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Sarcoidosis-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Sarcoidosis. This report provides information on the therapeutic development based on the Sarcoidosis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Sarcoidosis
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Sarcoidosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Sarcoidosis and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Sarcoidosis Overview
• Sarcoidosis Pipeline Therapeutics
• Sarcoidosis Therapeutics under Development by Companies
• Sarcoidosis Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Sarcoidosis Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Sarcoidosis Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Sarcoidosis Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Sarcoidosis – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Sarcoidosis – Discontinued Products
• Sarcoidosis – Dormant Products
• Companies Involved in Therapeutics Development for Sarcoidosis
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Sarcoidosis, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Sarcoidosis Assessment by Monotherapy Products
• Sarcoidosis Assessment by Combination Products
• Sarcoidosis Assessment by Route of Administration
• Sarcoidosis Assessment by Stage and Route of Administration
• Sarcoidosis Assessment by Molecule Type
• Sarcoidosis Assessment by Stage and Molecule Type
• Sarcoidosis Therapeutics – Discontinued Products
• Sarcoidosis Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for Sarcoidosis, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Sarcoidosis Assessment by Monotherapy Products
• Sarcoidosis Assessment by Combination Products
• Sarcoidosis Assessment by Route of Administration
• Sarcoidosis Assessment by Stage and Route of Administration
• Sarcoidosis Assessment by Molecule Type
• Sarcoidosis Assessment by Stage and Molecule Type


*** レポートのキーワード ***

サルコイドーシス(Sarcoidosis)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • Hitec Power Protection BV:企業概要及びSWOT分析
    Hitec Power Protection BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • 3SBio Inc. (SSRX)(製薬・医療分野):企業のM&A・提携動向
    Summary 3SBio Inc. (3SBio) is a fully integrated biotechnology company. It undertakes the research, development, manufacturing and marketing of biopharmaceutical products in China. It develops recombinant, or genetically engineered, protein-based products and product candidates to address large mark …
  • Standard Life plc (SL.) : 企業概要及びSWOT分析
    This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. WMI's 'Standard Life plc (SL.) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which a …
  • Ayen Enerji A.S. (AYEN):企業財務及びSWOT分析(エネルギー業界)
    Summary This comprehensive SWOT profile of Ayen Enerji A.S. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential …
  • 航空宇宙用医療検査装置の世界市場2018
    Aerospace Medical Test Device Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United …
  • 2014 Analysis of PSA Testing Technologies and Emerging Markets
    This report contains 249 pages, 15 tables and presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market …
  • 電子電圧計の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Electronic Voltmeters Revenue, means the sales value of Electronic Voltmeters This report studies sales (consumption) of Electronic Voltmeters in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countr …
  • 世界のスマートフォン用オーディオ・コーデック市場
    About Smartphone Audio Codecs A smartphone audio codec contains microphone and line inputs, signal routing and mixing channels, amplifier blocks, and multiple analog-to-digital converter (ADC) and digital-to-analog converter (DAC) channels. It also consists of a variety of output drivers, including …
  • Fresenius Kabi AG:企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • 無気肺(Atelectasis):世界の治験レビュー2014年下半期版
    Atelectasis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Atelectasis Global Clinical Trials Review, H2, 2014" provides data on the Atelectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atele …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVP501631 )"サルコイドーシス(Sarcoidosis):治療薬開発パイプライン動向2015" (英文:Sarcoidosis-Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。